Cryo-Cell International, Inc. (CCEL)
USD 5.52
(-2.39%)
USD 5.52
(-2.39%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 10.48 Million USD | 5.85% |
| 2022 | 9.91 Million USD | 282.11% |
| 2021 | -5.44 Million USD | -32.06% |
| 2020 | -4.12 Million USD | -270.62% |
| 2019 | 2.41 Million USD | -65.02% |
| 2018 | 6.9 Million USD | 579.46% |
| 2017 | 1.01 Million USD | -83.92% |
| 2016 | 6.31 Million USD | 312.38% |
| 2015 | -2.97 Million USD | -203.88% |
| 2014 | -979.26 Thousand USD | 39.74% |
| 2013 | -1.62 Million USD | -330.64% |
| 2012 | -377.38 Thousand USD | 85.23% |
| 2011 | -2.55 Million USD | -100.16% |
| 2010 | 1.61 Billion USD | -24.06% |
| 2009 | 2.12 Billion USD | 73.74% |
| 2008 | 1.22 Billion USD | -7.93% |
| 2007 | 1.32 Billion USD | -21.84% |
| 2006 | 1.69 Billion USD | 45.96% |
| 2005 | 1.16 Billion USD | -12.64% |
| 2004 | 1.33 Billion USD | 57849.6% |
| 2003 | -2.3 Million USD | -19.28% |
| 2002 | -1.93 Million USD | 61.81% |
| 2001 | -5.06 Million USD | -89.11% |
| 2000 | -2.67 Million USD | -91.3% |
| 1999 | -1.4 Million USD | -333.33% |
| 1998 | 600 Thousand USD | 300.0% |
| 1997 | -300 Thousand USD | 72.73% |
| 1996 | -1.1 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 11.3 Million USD | 7.81% |
| 2024 Q3 | 10.53 Million USD | -12.95% |
| 2024 Q2 | 13.24 Million USD | 17.15% |
| 2023 FY | 10.48 Million USD | 5.85% |
| 2023 Q2 | 10.5 Million USD | 9.01% |
| 2023 Q4 | 10.48 Million USD | -11.86% |
| 2023 Q1 | 9.63 Million USD | -2.76% |
| 2023 Q3 | 11.9 Million USD | 13.29% |
| 2022 Q4 | 9.91 Million USD | 51.78% |
| 2022 Q3 | 6.52 Million USD | 489.2% |
| 2022 Q1 | -168.37 Thousand USD | 96.91% |
| 2022 Q2 | -1.67 Million USD | -896.33% |
| 2022 FY | 9.91 Million USD | 282.11% |
| 2021 Q3 | -4.03 Million USD | -17.06% |
| 2021 FY | -5.44 Million USD | -32.06% |
| 2021 Q1 | -6.07 Million USD | -47.5% |
| 2021 Q2 | -3.45 Million USD | 43.22% |
| 2021 Q4 | -5.44 Million USD | -34.7% |
| 2020 Q1 | 286.46 Thousand USD | -88.14% |
| 2020 Q2 | -535 Thousand USD | -286.76% |
| 2020 Q3 | -1.04 Million USD | -95.07% |
| 2020 Q4 | -4.12 Million USD | -294.85% |
| 2020 FY | -4.12 Million USD | -270.62% |
| 2019 Q1 | 5.12 Million USD | -25.8% |
| 2019 Q2 | 4.98 Million USD | -2.73% |
| 2019 FY | 2.41 Million USD | -65.02% |
| 2019 Q3 | 2.36 Million USD | -52.52% |
| 2019 Q4 | 2.41 Million USD | 2.09% |
| 2018 Q4 | 6.9 Million USD | -9.75% |
| 2018 FY | 6.9 Million USD | 579.46% |
| 2018 Q3 | 7.64 Million USD | 4037.59% |
| 2018 Q2 | -194.25 Thousand USD | -14.6% |
| 2018 Q1 | -169.51 Thousand USD | -116.68% |
| 2017 Q4 | 1.01 Million USD | -67.22% |
| 2017 FY | 1.01 Million USD | -83.92% |
| 2017 Q1 | 5.84 Million USD | -7.49% |
| 2017 Q2 | 4.18 Million USD | -28.36% |
| 2017 Q3 | 3.09 Million USD | -25.99% |
| 2016 Q4 | 6.31 Million USD | -26.72% |
| 2016 Q2 | -3.86 Million USD | -55.84% |
| 2016 FY | 6.31 Million USD | 312.38% |
| 2016 Q3 | 8.62 Million USD | 323.07% |
| 2016 Q1 | -2.48 Million USD | 16.63% |
| 2015 Q4 | -2.97 Million USD | -102.63% |
| 2015 Q2 | -1.61 Million USD | -29.1% |
| 2015 Q3 | -1.46 Million USD | 9.01% |
| 2015 FY | -2.97 Million USD | -203.88% |
| 2015 Q1 | -1.25 Million USD | -27.67% |
| 2014 Q3 | -1.14 Million USD | -4.1% |
| 2014 Q4 | -979.26 Thousand USD | 14.77% |
| 2014 Q2 | -1.1 Million USD | -17.04% |
| 2014 FY | -979.26 Thousand USD | 39.74% |
| 2014 Q1 | -943 Thousand USD | 41.97% |
| 2013 Q1 | -559.05 Thousand USD | -48.14% |
| 2013 Q4 | -1.62 Million USD | -13.83% |
| 2013 FY | -1.62 Million USD | -330.64% |
| 2013 Q3 | -1.42 Million USD | -136.2% |
| 2013 Q2 | -604.46 Thousand USD | -8.12% |
| 2012 Q2 | -151.75 Thousand USD | 89.68% |
| 2012 Q3 | -213.6 Thousand USD | -40.76% |
| 2012 Q1 | -1.47 Million USD | 42.47% |
| 2012 FY | -377.38 Thousand USD | 85.23% |
| 2012 Q4 | -377.38 Thousand USD | -76.67% |
| 2011 Q4 | -2.55 Million USD | -20.33% |
| 2011 Q2 | 1.79 Billion USD | 2.59% |
| 2011 Q1 | 1.74 Billion USD | 8.45% |
| 2011 FY | -2.55 Million USD | -100.16% |
| 2011 Q3 | -2.12 Million USD | -100.12% |
| 2010 Q2 | 1.82 Billion USD | 4.6% |
| 2010 FY | 1.61 Billion USD | -24.06% |
| 2010 Q1 | 1.74 Billion USD | -17.78% |
| 2010 Q4 | 1.61 Billion USD | -5.62% |
| 2010 Q3 | 1.7 Billion USD | -6.45% |
| 2009 Q2 | 1.45 Billion USD | 3.61% |
| 2009 Q3 | 1.63 Billion USD | 12.53% |
| 2009 Q4 | 2.12 Billion USD | 30.02% |
| 2009 FY | 2.12 Billion USD | 73.74% |
| 2009 Q1 | 1.4 Billion USD | 14.61% |
| 2008 Q4 | 1.22 Billion USD | -3.73% |
| 2008 Q3 | 1.26 Billion USD | 4.38% |
| 2008 FY | 1.22 Billion USD | -7.93% |
| 2008 Q1 | 1.38 Billion USD | 3.95% |
| 2008 Q2 | 1.21 Billion USD | -11.86% |
| 2007 Q4 | 1.32 Billion USD | 29.15% |
| 2007 FY | 1.32 Billion USD | -21.84% |
| 2007 Q3 | 1.02 Billion USD | 1.74% |
| 2007 Q2 | 1.01 Billion USD | -35.2% |
| 2007 Q1 | 1.55 Billion USD | -8.2% |
| 2006 FY | 1.69 Billion USD | 45.96% |
| 2006 Q1 | 1.11 Billion USD | -4.47% |
| 2006 Q3 | 1.74 Billion USD | 41.54% |
| 2006 Q4 | 1.69 Billion USD | -2.88% |
| 2006 Q2 | 1.23 Billion USD | 11.14% |
| 2005 Q1 | 848.68 Million USD | -36.3% |
| 2005 FY | 1.16 Billion USD | -12.64% |
| 2005 Q4 | 1.16 Billion USD | 65.01% |
| 2005 Q3 | 705.34 Million USD | -31.31% |
| 2005 Q2 | 1.02 Billion USD | 20.99% |
| 2004 Q4 | 1.33 Billion USD | 82.55% |
| 2004 Q2 | 2.05 Billion USD | 86119.54% |
| 2004 Q1 | -2.39 Million USD | -3.65% |
| 2004 FY | 1.33 Billion USD | 57849.6% |
| 2004 Q3 | 729.81 Million USD | -64.52% |
| 2003 FY | -2.3 Million USD | -19.28% |
| 2003 Q1 | 904.39 Million USD | 46859.88% |
| 2003 Q3 | -374.41 Thousand USD | 45.91% |
| 2003 Q2 | -692.26 Thousand USD | -100.08% |
| 2003 Q4 | -2.3 Million USD | -516.16% |
| 2002 FY | -1.93 Million USD | 61.81% |
| 2002 Q4 | -1.93 Million USD | 63.72% |
| 2002 Q2 | -6.04 Million USD | -12.6% |
| 2002 Q3 | -5.33 Million USD | 11.73% |
| 2002 Q1 | -5.36 Million USD | -5.91% |
| 2001 FY | -5.06 Million USD | -89.11% |
| 2001 Q1 | -2.54 Million USD | 4.96% |
| 2001 Q2 | -2.28 Million USD | 10.23% |
| 2001 Q4 | -5.06 Million USD | 1.52% |
| 2001 Q3 | -5.14 Million USD | -125.08% |
| 2000 Q2 | -3.11 Million USD | -106.6% |
| 2000 FY | -2.67 Million USD | -91.3% |
| 2000 Q1 | -1.5 Million USD | -7.62% |
| 2000 Q3 | -3.29 Million USD | -5.99% |
| 2000 Q4 | -2.67 Million USD | 18.82% |
| 1999 Q1 | -300 Thousand USD | -150.0% |
| 1999 FY | -1.4 Million USD | -333.33% |
| 1999 Q2 | -100 Thousand USD | 66.67% |
| 1999 Q3 | -100 Thousand USD | 0.0% |
| 1999 Q4 | -1.4 Million USD | -1300.0% |
| 1998 Q3 | 500 Thousand USD | 0.0% |
| 1998 Q1 | - USD | 100.0% |
| 1998 Q2 | 500 Thousand USD | 0.0% |
| 1998 FY | 600 Thousand USD | 300.0% |
| 1998 Q4 | 600 Thousand USD | 20.0% |
| 1997 FY | -300 Thousand USD | 72.73% |
| 1997 Q1 | -1.2 Million USD | -9.09% |
| 1997 Q4 | -300 Thousand USD | 57.14% |
| 1997 Q3 | -700 Thousand USD | 46.15% |
| 1997 Q2 | -1.3 Million USD | -8.33% |
| 1996 FY | -1.1 Million USD | 0.0% |
| 1996 Q4 | -1.1 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 99.256% |
| Addus HomeCare Corporation | 110.39 Million USD | 90.497% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | 88.267% |
| Amedisys, Inc. | 341.35 Million USD | 96.927% |
| American Oncology Network, Inc. | 99.78 Million USD | 89.488% |
| Astrana Health, Inc. | 27.2 Million USD | 61.444% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 99.279% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 4835.64% |
| biote Corp. | 25.86 Million USD | 59.45% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 188.695% |
| COMPASS Pathways plc | -187.58 Million USD | 105.592% |
| DocGo Inc. | -12.78 Million USD | 182.023% |
| The Ensign Group, Inc. | 1.36 Billion USD | 99.23% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 198.083% |
| InnovAge Holding Corp. | 56.08 Million USD | 81.298% |
| Assure Holdings Corp. | 14.68 Million USD | 28.552% |
| The Joint Corp. | -2.47 Million USD | 523.075% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 97.573% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 273.372% |
| ModivCare Inc. | 1.13 Billion USD | 99.078% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -3667.283% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | -158.671% |
| Option Care Health, Inc. | 822.56 Million USD | 98.725% |
| P3 Health Partners Inc. | 83.7 Million USD | 87.468% |
| P3 Health Partners Inc. | 83.7 Million USD | 87.468% |
| The Pennant Group, Inc. | 323.57 Million USD | 96.758% |
| Surgery Partners, Inc. | 2.86 Billion USD | 99.634% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 445.978% |
| Talkspace, Inc. | -123.9 Million USD | 108.466% |
| Talkspace, Inc. | -123.9 Million USD | 108.466% |
| The Oncology Institute, Inc. | 86.32 Million USD | 87.849% |
| The Oncology Institute, Inc. | 86.32 Million USD | 87.849% |